C4 Therapeutics, Inc. (CCCC) Total liabilities 2021–2025
C4 Therapeutics, Inc. (CCCC) total liabilities at each fiscal year-end, per SEC filings.
$102.5MFY2025 · since FY2021: $117.2M → $102.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $102.5M | -23.3% |
| FY2024 | $133.6M | +2.5% |
| FY2023 | $130.3M | -8.0% |
| FY2022 | $141.6M | +20.9% |
| FY2021 | $117.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice